Anti-Human EGFR Recombinant Antibody(Nimotuzumab)
-
产品编号
YR1033
-
别名
科研级 Nimotuzumab ( 尼妥组单抗 ), Anti-EGFR Recombinant Antibody, Research Grade Nimotuzumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Nimotuzumab ( 尼妥组单抗 ), Anti-EGFR Recombinant Antibody, Research Grade Nimotuzumab |
Catalog Number | YR1033 |
Molecular Name | Nimotuzumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Nimotuzumab (h-R3, BIOMAb EGFR, Biocon, India, TheraCIM, CIMYM Biosciences, Canada, Theraloc, Oncoscience, Europe, CIMAher, Center of Molecular Immunology, Havana, Cuba) is a humanized monoclonal antibody that as of 2014 had orphan status in the US and EU for glioma, and marketing approval in India, China, and other countries for squamous cell carcinomas of the head and neck, and was undergoing several clinical trials. |
CAS Number | 828933-51-3 |
Application | ELISA, IP, FCM, FuncS, Neut, IF, IHC |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Molecular Weight | 148 kDa |
Target | EGFR[Homo sapiens] |